Annovis Bio Inc (ANVS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ANVS Annual Balance Sheets →
Balance sheet patterns shown here provide context for understanding Annovis Bio Inc's financial stability and long-term positioning.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent18.73
Cash, Cash Equivalents Other0.01
Cash & Short-term Investments18.00
Total loans net0.52
Total Current Assets19.26
Other Assets, Noncurrent2.78
Prepaid Expense Security Deposits And Other Assets Current2.02
Total Assets22.04
Liabilities
Accounts Payable, Current AC3.33
Accrued Liabilities, Current0.55
Other Liabilities, Current2.48
Total Current Liabilities6.36
Total Long-term Debt0.00
Other liabilities, Noncurrent19.93
Accrued Liabilities And Interest And Employee Related Liabilities Current7.51
Warrant Liability Noncurrent0.33
Total Liabilities26.29
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock191.87
Retained Earnings / Accumulated Deficit-196.13
Other Equity0.00
Common Stockholder's Equity-4.25
Total Stockholder's Equity-4.25
Liabilities & Stockholder's Equity22.04
4 historic quarters locked

Sign in to unlock the full Annovis Bio Inc balance sheet history.

About Annovis Bio Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-097228

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.